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Abstract 
The best reaction condition of the labeling processing and the best concentration of the monoclonal antibody of direct 
immunofluorescence assay for Ureaplasma Urealyticum (UU) were firstly researched. To evaluate the performance 
of the corresponding Ureaplasma Urealyticum detection kit (Immunofluorescence) through clinical trials, a parallel-
controlled method was carried out, and the clinical specimens were tested by the immunofluorescence detection kit 
and also isolated culture, which was applied as gold standard. Total 1100 samples were tested, and the overall 
coincidence rate was 95.82%. The positive coincidence rate was 94.87%, and the negative coincidence rate was 
96.26%, and the Kappa value surpassed 0.8, which indicated that there was no significant difference between the 
results of the immunofluorescence detection kit and of isolated culture. The Ureaplasma Urealyticum 
immunofluorescence detection kit by Microprofit owns the potential of providing a rapid, accurate, simple and 
economical clinical detection means for Ureaplasma Urealyticum. 
© 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of [name organizer] 
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1.Introduction 
Since 2001, the incidence of nongonococcal urethritis stands first on the list of eight kinds of 
sexually transmitted diseases in China[1].Ureaplasma Urealyticum (UU) is one of the main causes of 
nongonococcal urethritisit can cause chronic prostatitis, cervicitis, pelvic inflammatory disease,habitual 
abortion,stillbirth,low birth weight and infertility and other diseases.And the trend of Ureaplasma 
urealyticum infection incidence is increasing[2]. At present,the detection methods of Ureaplasma 
urealyticum are culture, antigens detection, molecular biology method, antibodies detection method and 
so on[3]. The culture medium is not easy to be kept for a long time, more steps in cultivation and 
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identification and long training cycle, and low sensitivity in culture method, so the result relatively prone 
to false negative. PCR method for the detection of Ureaplasma urealyticum is high false positive. Enzyme 
immunoassay for detection of Ureaplasma urealyticum antibody can not reflect the true infection, and 
appears nonspecific reaction. So it is very important to choose a fast and accurate method. This study 
established the immunofluorescence assay for detection of Ureaplasma urealyticum, is in order to find a 
quick detection method. At last, using the immunofluorescence detection kit to detect the 1100 cases of 
clinical samples, and comparing with culture method, the purpose is to evaluate the kit’s clinical value.
2.Establishment immunofluorescence detection kit for Ureaplasma urealyticum 
2.1 Establishment labeled method 
Antibodies which developed by Shenzhen microprofit is specificity with Ureaplasma urealyticum 
surface protein. Compare three kinds of method for labeling fluorescein isothiocyanate (FITC) fluorescein 
on antibody, respectively: 
y Protocal method 
Draw a certain DMSO solution which containing FITC, slow to join the IgG solution which 
preparation by pH9.5 carbonate buffer solution, use a tumbling type cradle rotating 1 hour at room 
temperature ( 20-25 degrees). 
y Marsshall method 
Stir and join the FITC into the IgG solution gradually (finished within 5-10min), and then 
electromagnetic stirring 12-18h at 4 degrees. 
y Dialysis labeling method 
Put the IgG solution into the dialysis bag, immerse the dialysis bag in 10 times volume FITC 
carbonate buffer solution, and then electromagnetic stirring 24h at 4 degrees. 
Use the control slide which prepared by Shenzhen Third People’s Hospital to test fluorescent antibody 
labeling by different methods. The results show in Table 1: 







2̚8ć˖7days 10/10 10/10 
(37±1)ć˖7days 10/10 10/10 
Marsshall 
2̚8ć˖7 days 9/10 10/10 
(37±1)ć˖7days 9/10 10/10 
Dialysis
labeling
2̚8ć˖7days 10/10 10/10 
(37±1)ć˖7days 10/10 10/10 
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Table 1shows the results of sensitivity, specificity and thermal stability without difference between 
three kinds of fluorescent antibody labeling by different methods. Protocal method is simple, easy to 
control, shorter time, so choose Protocal method for fluorescence antibody labeling method. 
2.2 Establishment the optimum reaction conditions 
At 37 degrees, use quality control to test different combination experiment about fluorescent 
antibody amount and reaction time, and establish the optimum reaction conditions, The fluorescent 
strength and background stain 5 grades with "0, 1, 2, 3, 4, 5"," 5" is very strong positive," 4" is stronger 
positive," 3 " is strongly positive," 2 " is weaker positive," 1" is very weak positive," 0" is negative. The 
results show in Table 2, table 3 and table 4: 
Table2. Experimental results of reaction condition(1) 
Item 
reaction1 reaction2 reaction3 
quantity 
5ul 5ul 5ul 












3 0 5 0 5 3 
2 0 3 0 3 1 
1 0 1 0 1 0 
1 0 2 0 2 1 
2 0 4 0 4 2 
Coincidence 
rate
5/5 5/5 5/5 5/5 5/5 5/5 
Table3. Experimental results of reaction condition (2) 
Item reaction4 reaction5 reaction6 
quantity 10ul 10ul 10ul 












3 1 5 0 5 3 
2 0 3 0 3 1 
1 0 1 0 1 0 
1 0 2 0 2 1 
2 0 4 0 4 2 
Coincidence 
rate
5/5 5/5 5/5 5/5 5/5 5/5 
Table4. Experimental results of reaction condition (3) 
Item reaction7 reaction8 reaction9 
quantity 20ul 20ul 20ul 
Reaction time 15min 30min 45min 












3 1 5 0 5 3 
2 0 3 0 3 1 
1 0 1 0 1 0 
1 0 2 0 2 1 
2 0 4 0 4 2 
Coincidence 
rate
5/5 5/5 5/5 5/5 5/5 5/5 
The results show that reaction 2 (amount 5ul, reaction time 30min) use less reagent and the 
sensitivity and specificity are very good, so choose the reaction 2 as the optimal reaction conditions. 
2.3 Establishment suitable concentration of fluorescence antibodies 
Test quality control (P1 is very strong positive control, P2 is strongly positive control, P3 is very 
weak positive control, N1 is negative control) at the optimal reaction conditions to confirm the suitable 
concentration of fluorescence antibodies. The results show in Table 5: 
Table5. Experimental results of antibody dilution 
dilution 













1:5 5 2 3 2 1 1 0 2 
1:10 5 1 3 1 1 0 0 1 
1:20 5 0 3 0 1 0 0 0 
1:30 4 0 2 0 1 0 0 0 
1:40 3 0 2 0 0 0 0 0 
1:50 2 0 1 0 0 0 0 0 
1:100 1 0 0 0 0 0 0 0 
The results show that the dilution of 1:20(i.e., using 50ug / ml as antibody optimal concentration) is 
the optimal dilution. 
2.4 Establishment reaction system 
Comparison of the above reaction conditions and different concentrations of the antibodies, at last we 
select the reation system is: 5 UL fluorescent antibody reagent, 37 degrees temperature at 30 min, and 
antibody dilution 1: 20 (50ug / ml antibody optimal concentration). The best reaction conditions show in 
Figure 1: 
Figure 1. The brief flow chart conditon of the reaction 
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3.Evaluation the clinical application of reagent kit for detection of Ureaplasma urealyticum 
(immunofluorescence)  
3.1 Materials and methods 
y Sample 
At April to October of 2009, a total of 1100 specimens were collected from Obstetrics, Gynecology 
and others of Shenzhen Third People’s Hospital and other two drug clinical trial bases. Samples are label 
with number in order to ensure the privacy of the patients. Use the immunofluorescence reagent kit and 
culture method for double blind parallel to test the specimens, use culture method as the gold standard. 
Patients relate to different regions, diseased or not sick peoples, and people are area representative. 
Women specimens were collected from cervical, male specimens were collected from urethral. 
y Reagent and instrument 
Reagent˖reagent kit for detection of Ureaplasma urealyticum (immunofluorescence) ( Specification 
for 50 / box, batch: 20090301),are provided by Shenzhen Microprofit biological technology limited 
company; Mycoplasma identification medium ( BP0205 specifications, batch: 827847401, 827843210, 
827846003), are provided by Jiangmen Crmicrobio company. 
Instrument: CX41/Olympus Fluorescence microscope 
y Operation 
Operate Mycoplasma identification medium strictly according to the instructions, culture 24h ~ 48h 
at 37 degrees, observes the results. The liquid medium turn red from yellow, transparent and turbid, 
appear diameter 15 u m ~ 50 / M core, rough, granular, with extremely narrow edge, a fried egg shaped 
colonies in the solid medium culture  were identified as positive. 
Reagent kit for detection of Ureaplasma urealyticum (immunofluore- scence) process: apply the 
sample gently in a clean glass slide, air fully, then use methanol fixation 10 minutes, natural drying. Even 
drop the reagent in the glass coating, incubate 30 minutes at 37 degrees. After incubation, use distilled 
water slowly flushing slide several times, each time 5 ~ 10 seconds, natural drying using. Use 
fluorescence microscopy to read the results, and search Apple Green typical small hammer Ureaplasma 
urealyticum particles at 100 times objective lens. Found more than 10 apple green typical small hammer 
Ureaplasma urealyticum particles which is positive, which was not found to be defined as positive typical 
specific staining is negative. 
y Data processing 
Using SPSS statistical analysis software to statistically analyze the testing results, calculate the 
negative, positive coincidence rate and accuracy of Microprofit kit and culture method, and calculate 
Kappa (K) value. If the K value > 0.8, show that two kinds of detection methods are highly equivalence. 
3.2 Result 
Respectively use the immunofluorescence reagent kit and culture method for double blind parallel 
to test the specimens, test results are shown in table 6. 
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positive 333 28 361 
negative 18 721 739 
total 351 749 1100 
The total coincidence was 95.82%, the positive coincidence was 94.87%, the negative coincidence up 
to 96.26% of the two methods for the detection of Ureaplasma urealyticum in clinical samples. The 
Kappa (K) is 0.9045, which show two kits were no differences. Fig 2 is Ureaplasma Urealyticum 
immunofluorescence image in clinical sample, figure 2 (a) is a typical positive image, figure 2 (b) is a 
typical negative image. 
         
Figure 2(a). Positive Image           Figure 2(b). Negative Image 
           
Figure 2. Clinical sample effect of the immunofluorescence detection kit 
4.Discussion 
Mycoplasma is the common pathogens of the Urogenital tract inflammation, and the main causes of 
nongonococcal urethritisit. Ureaplasma Urealyticum (UU) is considered to be the most common 
pathogens, especially in female patients with higher detectable rate[4]. There are reports, Ureaplasma 
urealyticum was high detection rate to 60% in the female pateins[5]. As the basic and clinical research, 
more evidence indicates that there are close relationship between Ureaplasma urealyticum and abortion, 
premature delivery, infertility, female genital tract, low birth weight and other diseases. In recent years, 
the trend of Ureaplasma urealyticum infection incidence is increasing year by year[6], Ureaplasma 
urealyticum have attracted clinical attention on human urogenital infections. Liquid - solid two steps 
culture with high accuracy, is the “gold standard” of detection Ureaplasma urealyticum, but the positive 
rate is lower, and cann’t carry out drug test; liquid - liquid two steps culture has better sensitivity and 
specificity, is the routine method detection for Ureaplasma urealyticum,is simple, practical, and can be 
used to do drug test [7]. Currently, most of the mycoplasma reagent is liquid medium, with the color 
whether reddening to judge the growth of mycoplasma[8]. The culture method have more steps in 
cultivation and identification and long training cycle, and low sensitivity, so the result relatively prone to 
false negative. PCR has better accuracy and specificity, but the PCR instrument is highly sensitive, need 
professional laboratory personnel and professional environment, and is easy affect by experimental 
process, sample and variety of factors. Immunofluorescence method is a marking technology base on 
immunology, biochemistry and fluorescence microscopy technique. The principle is that play fluorescein 
directly to label antibody, which isn’t affected the antigen and antibody activity, and the antigen-
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antibody- fluorescein bindings in sample will show specific fluorescence imaging. Do not require cell 
viability and periodic incubated to meet the needs of various types of sugars tested, thus 
immunofluorescence assay has significant application[9]. Compared with other detection methods, 
because with good specificity and high sensitivity, this technique is the first choice[9]. Monoclonal 
antibody immunofluorescence assay is fast, easy operation, good specificity, and high consistency with 
culture method for detection for Mycoplasma urealytium. In the detection of the endometrium and tubal 
specimen, Immunofluorescence method has high sensitivity to culture. And Immunofluorescence method 
also be used for semen, rectal specimens which easy for transport and poorly preserved to miss 
Ureaplasma urealyticum. From the test results, The reagent kit for detection of Ureaplasma Urealyticum 
(immunofluorescence) from Microprofit was compared with culture method. The coincidence rate of 
Microprofit kit was 95.82% compared to culture. The positive coincidence was 94.87%. The negative 
coincidence was 96.26%, and the two methods was high coincidence( Kappa > 0.8 ). The reagent kit for 
detection of Ureaplasma Urealyticum (immunofluorescence) from Microprofit also has a simple, 
economical and practical features, is suitable for clinical detection. 
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